Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.

[1]  A. Browning,et al.  The effects of growth factors on the proliferation and in vitro angiogenesis of human macular inner choroidal endothelial cells , 2008, British Journal of Ophthalmology.

[2]  H. Yamashita,et al.  Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion , 2008, Eye.

[3]  L. Rangell,et al.  PHARMACOKINETICS AND RETINAL DISTRIBUTION OF RANIBIZUMAB, A HUMANIZED ANTIBODY FRAGMENT DIRECTED AGAINST VEGF-A, FOLLOWING INTRAVITREAL ADMINISTRATION IN RABBITS , 2007, Retina.

[4]  Y. Ogura,et al.  Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice. , 2007, Investigative ophthalmology & visual science.

[5]  Philip J Rosenfeld,et al.  Ranibizumab for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.

[6]  J. Duker,et al.  A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. , 2006, Ophthalmology.

[7]  R. Apte,et al.  Macrophages Inhibit Neovascularization in a Murine Model of Age-Related Macular Degeneration , 2006, PLoS medicine.

[8]  A. Joussen,et al.  Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization. , 2006, Experimental eye research.

[9]  M. Mochizuki,et al.  Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis. , 2006, Investigative ophthalmology & visual science.

[10]  K. Choy,et al.  Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. , 2006, American journal of ophthalmology.

[11]  S. Lightman,et al.  Multiplex cytokine detection versus ELISA for aqueous humor: IL-5, IL-10, and IFNgamma profiles in uveitis. , 2006, Investigative ophthalmology & visual science.

[12]  Napoleone Ferrara,et al.  Angiogenesis as a therapeutic target , 2005, Nature.

[13]  D. Fei,et al.  Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration. , 2005, Investigative ophthalmology & visual science.

[14]  Napoleone Ferrara,et al.  Vascular endothelial growth factor: basic science and clinical progress. , 2004, Endocrine reviews.

[15]  Alan W. Stitt,et al.  Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy. , 2004, The American journal of pathology.

[16]  Joan W. Miller,et al.  VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal Neovascularization , 2003, The Journal of experimental medicine.

[17]  H. Grossniklaus,et al.  Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. , 2002, Molecular vision.

[18]  P. Campochiaro,et al.  Platelet-derived growth factor-A-induced retinal gliosis protects against ischemic retinopathy. , 2000, The American journal of pathology.

[19]  A Kijlstra,et al.  Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. , 1999, The American journal of pathology.

[20]  C. Heldin,et al.  Signal transduction via platelet-derived growth factor receptors. , 1998, Biochimica et biophysica acta.

[21]  A. Palotie,et al.  Peripheral Blood Platelets Express VEGF-C and VEGF which Are Released during Platelet Activation , 1998, Thrombosis and Haemostasis.

[22]  D. Yew,et al.  Time-course expression of vascular endothelial growth factor as related to the development of the retinochoroidal vasculature in rats , 1998, Experimental Brain Research.

[23]  J. El Benna,et al.  Intracellular pool of vascular endothelial growth factor in human neutrophils. , 1997, Blood.

[24]  B R Johansson,et al.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.

[25]  P. D. de Jong,et al.  Increased expression of angiogenic growth factors in age-related maculopathy , 1997, The British journal of ophthalmology.

[26]  S. Seregard,et al.  Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. , 1996, Investigative ophthalmology & visual science.

[27]  L. Aiello,et al.  Hypoxic regulation of vascular endothelial growth factor in retinal cells. , 1995, Archives of ophthalmology.

[28]  J. Stone,et al.  Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.

[30]  N. Yoshimura,et al.  Platelet-derived growth factor gene expression in cultured human retinal pigment epithelial cells. , 1992, Biochemical and biophysical research communications.